Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Workday
WDAY
$39B
| $63M | 0.03% |
305,043
+93,008
| +44% | +$16.9M |
|
377
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
| $63M | 0.03% |
622,250
-456,007
| -42% | -$45.9M |
|
378
PACCAR
PCAR
$70.4B
| $62.8M | 0.03% |
857,846
-176,730
| -17% | -$12.6M |
|
379
MSCI
MSCI
$41.9B
| $62.6M | 0.03% |
111,925
-23,494
| -17% | -$12.4M |
|
380
Sarepta Therapeutics
SRPT
$1.64B
| $62.5M | 0.03% |
453,610
+38,602
| +9% | +$5.01M |
|
381
FirstEnergy
FE
$28.2B
| $62M | 0.03% |
1,548,597
-35,302
| -2% | -$1.43M |
|
382
Kroger
KR
$35.4B
| $62M | 0.03% |
1,256,466
-603,248
| -32% | -$27.6M |
|
|
383
PUT
UnitedHealth
UNH
$383B
| $61.8M | 0.03% |
130,800
-51,000
| -28% | -$24.6M |
|
384
Albemarle
ALB
$13.9B
| $61.7M | 0.03% |
279,089
-101,355
| -27% | -$25M |
|
385
CALL
Enphase Energy
ENPH
$4.94B
| $61.5M | 0.03% |
292,600
+181,700
| +164% | +$39.4M |
|
386
Pinduoduo
PDD
$124B
| $61.5M | 0.03% |
810,407
-2,825,976
| -78% | -$255M |
|
387
Lamb Weston
LW
$7.36B
| $61.4M | 0.03% |
587,130
-282,748
| -33% | -$28M |
|
388
Texas Roadhouse
TXRH
$13.7B
| $61.3M | 0.03% |
567,075
-4,943
| -0.9% | -$506K |
|
389
L3Harris
LHX
$50.7B
| $61.2M | 0.03% |
311,658
+53,059
| +21% | +$10.8M |
|
390
CALL
Procter & Gamble
PG
$335B
| $61M | 0.03% |
410,400
+146,000
| +55% | +$20.9M |
|
391
CALL
Chevron
CVX
$383B
| $60.7M | 0.03% |
371,900
+227,500
| +158% | +$38.1M |
|
392
PUT
Philip Morris
PM
$299B
| $60.6M | 0.03% |
623,000
+422,000
| +210% | +$42.1M |
|
393
Moody's
MCO
$83.5B
| $60.3M | 0.03% |
197,108
-230,540
| -54% | -$69.7M |
|
394
PUT
Occidental Petroleum
OXY
$55.6B
| $60.3M | 0.03% |
965,800
+815,800
| +544% | +$50.7M |
|
395
Las Vegas Sands
LVS
$32.3B
| $60.3M | 0.03% |
1,049,238
-836,936
| -44% | -$46.9M |
|
396
Equinix
EQIX
$103B
| $60.2M | 0.03% |
83,485
-102,250
| -55% | -$72M |
|
397
ASML
ASML
$634B
| $60.1M | 0.03% |
88,321
+16,745
| +23% | +$10.8M |
|
398
Capital One
COF
$129B
| $60M | 0.03% |
624,107
-523,049
| -46% | -$54.7M |
|
399
Liberty Broadband Class C
LBRDK
$4.79B
| $60M | 0.03% |
733,953
+91,690
| +14% | +$7.91M |
|
400
PUT
Carnival Corporation Ltd
CCL
$38B
| $59.6M | 0.03% |
5,875,900
+2,851,900
| +94% | +$29.5M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.